US Supreme Court Scales Back Roundup Cancer Lawsuits

The U.S. Supreme Court ruled to limit the scope of thousands of cancer lawsuits against Bayer's Roundup, deciding that claims must be brought in federal court rather than state courts. This decision is a significant win for Bayer, as it centralizes legal proceedings and potentially shields the company from a barrage of individual state-level litigations. The ruling underscores the complexities surrounding product liability and cancer causation, highlighting the importance of federal versus state jurisdiction in handling such cases. This move could set a precedent for future litigations involving similar claims against other products.